JMF
CRL icon

Johnson Midwest Financial’s Charles River Laboratories CRL Stock Holding History

Johnson Midwest Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.53K Hold
18
– – 0.01% 283
2023
Q2 		$3.79K Hold
18
– – ﹤0.01% 281
2023
Q1 		$3.63K Hold
18
– – 0.01% 294
2022
Q4 		$4K Buy
+18
New +$3.93K 0.01% 281

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Johnson Midwest Financial's CRL Position: Q3 2023 in Review

Johnson Midwest Financial held its Charles River Laboratories (CRL) position steady in Q3 2023 at 18 shares worth $3.53K. The position accounts for 0.01% of the portfolio, ranked #283.

Johnson Midwest Financial first reported a position in CRL in Q4 2022 and has held it in 4 quarters since. The position peaked at $4K in Q4 2022. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Johnson Midwest Financial held 18 shares of Charles River Laboratories worth $3.53K as of Q3 2023.
  • Johnson Midwest Financial left its Charles River Laboratories share count unchanged in Q3 2023.
  • Charles River Laboratories made up 0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #283 holding.
  • Johnson Midwest Financial first reported a position in Charles River Laboratories in Q4 2022 and has held it in 4 quarters since.
  • Johnson Midwest Financial's Charles River Laboratories position peaked at $4K in Q4 2022.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.